Letter by Campochiaro et al Regarding Article, "Clinical Features, Management, and Outcomes of Immune Checkpoint Inhibitor-Related Cardiotoxicity"

Circulation. 2018 May 29;137(22):2421-2422. doi: 10.1161/CIRCULATIONAHA.117.033305.

Authors

Corrado Campochiaro¹, Giacomo De Luca¹, Giulio Cavalli¹

Affiliation

¹ Unit of Immunology, Rheumatology, Allergy, and Rare Diseases (UnIRAR), IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy.

PMID: 29844079
DOI: 10.1161/CIRCULATIONAHA.117.033305

No abstract available

Publication types

Letter
Comment

MeSH terms

Cardiotoxicity*
Heart Diseases / immunology*
Humans
Immunologic Factors

Substances

Immunologic Factors